financetom
Business
financetom
/
Business
/
Global property insurers see 'alarming' losses as risk models lag, report says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Global property insurers see 'alarming' losses as risk models lag, report says
Apr 16, 2024 4:39 PM

LONDON (Reuters) - Global property and casualty insurers showed "alarming" underwriting losses in 2022 as natural catastrophes increased and risk models failed to keep up, a report from consultants Capgemini said on Wednesday.

Global insured losses from natural catastrophes have been surpassing $100 billion annually in recent years, driven higher by issues such as winter storms. Industry sources see climate change and increased building in exposed areas as contributing to the losses.

The insurers' global combined ratio, a measure of claims and expenses against premium revenue, was 103% in 2022, Capgemini said. A level above 100 indicates an underwriting loss. Property insurers have suffered three years of underwriting losses in the past four years, the report said.

Only 27% of insurance executives surveyed believe their firms have advanced predictive modelling capabilities.

"Accurate risk prediction and pricing are becoming increasingly challenging and leading to insurability concerns," Anirban Bose, Capgemini financial services strategic business unit CEO, said in the report.

The report gathered information from 18 insurance markets, including Britain, Hong Kong, India and the United States, through polling of insurance customers and interviews with insurance executives and underwriters.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Toyota Requires North American Salaried Workers to Return to Office
Market Chatter: Toyota Requires North American Salaried Workers to Return to Office
Jan 13, 2025
03:05 PM EST, 01/13/2025 (MT Newswires) -- Toyota Motor ( TM ) has decided that North American salaried workers will return to the office Monday through Thursday, Bloomberg News reported Monday, citing an internal memo. The mandate applies to all job levels at Toyota Motor North America and Toyota Financial Services, excluding specific roles, the media outlet reported. The requirement...
McDonald's sued over Latino scholarships despite rolling back diversity initiatives
McDonald's sued over Latino scholarships despite rolling back diversity initiatives
Jan 13, 2025
* Lawsuit claims scholarship program discriminates against non-Latino students * McDonald's reviewing programs amid diversity initiative changes * Blum's group challenges corporate diversity programs post-Supreme Court ruling By Nate Raymond Jan 13 (Reuters) - A group opposed to affirmative action filed a lawsuit accusing McDonald's of not going far enough when it recently rolled back several diversity initiatives by continuing...
EU considers expanding probe into Musk's X, Bloomberg News says
EU considers expanding probe into Musk's X, Bloomberg News says
Jan 13, 2025
(Reuters) - The European Union is considering expanding its investigation into whether Elon Musk's social media network X breached its content moderation rulebook, Bloomberg News reported on Monday, citing the bloc's tech policy chief. The EU started investigating X, formerly Twitter, in late 2023 over suspected breaches of obligations, partly relating to posts following Hamas' attacks on Israel, its first...
Salarius Pharmaceuticals Shares Are Skyrocketing Today: What's Going On?
Salarius Pharmaceuticals Shares Are Skyrocketing Today: What's Going On?
Jan 13, 2025
Salarius Pharmaceuticals ( SLRX ) shares are trading higher Monday after the company announced a merger agreement with Decoy Therapeutics, a privately held biopharmaceutical company. What To Know: Under the agreement, Decoy Therapeutics will merge with a wholly owned subsidiary of Salarius Pharmaceuticals ( SLRX ) to form a new entity called Decoy Therapeutics. Following the merger and a shareholder...
Copyright 2023-2026 - www.financetom.com All Rights Reserved